Basal hyposecretion of gastric inhibitory polypeptide after Roux-Y hepaticojejunostomy in man.
We previously showed that basal and pentagastrin-stimulated gastric acid secretion, gastrin in serum and gastrin in antral mucosa were significantly greater in patients with Roux-Y hepaticojejunostomy than in those with choledochoduodenostomy. These findings prompted investigation of basal secretion of gastric inhibitory polypeptide (a peptide with an enterogastrone as well as an insulinogenic effect), insulin and glucose in the same patients. Basal gastric inhibitory polypeptide was significantly lower in patients with Roux-Y hepaticojejunostomy than in those with choledochoduodensotomy, whereas glucose and insulin did not differ in the two groups. No correlation could be demonstrated between gastric inhibitory polypeptide, gastric acid secretion and gastrin, suggesting that hyposecretion of gastric inhibitory polypeptide is not a pathogenetic factor for the hypersecretion of gastric acid secretion in patients with Roux-Y hepaticojejunostomy. Hyposecretion of gastric inhibitory polypeptide and gastric acid hypersecretion in patients with bile diversion seem to be two independent phenomena.
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003135:Common Bile Duct / Q000601:surgery; D004386:Duodenum / Q000601:surgery; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood / Q000378:metabolism*; D005750:Gastric Juice / Q000378:metabolism; D005755:Gastrins / Q000502:physiology; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D006500:Hepatic Duct, Common / Q000601:surgery*; D006801:Humans; D007328:Insulin / Q000097:blood; D007583:Jejunum / Q000601:surgery*; D008297:Male; D008875:Middle Aged
D001786:Blood Glucose; D005755:Gastrins; D005768:Gastrointestinal Hormones; D007328:Insulin; D005749:Gastric Inhibitory Polypeptide